Vesalius cell-mapping tool provides insightful multi-layered view of cancer behaviour
Researchers at VCU Massey Comprehensive Cancer Centre, USA, have developed a new computational tool called…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Stark regional disparities in cancer burden across India
A major cross-sectional analysis from the National Cancer Registry Programme (NCRP) Investigator Group has revealed…
Electronic symptom tracking boosts quality of life for patients on trastuzumab deruxtecan
A new multicentre randomised clinical trial suggests that electronic monitoring of patient-reported outcomes (ePROs) combined…
SAVETHEBOTTOMS!!! Community-based anal cancer screening shows promise for MSM and transgender women
A recent JAMA Surgery study by Welton et al. evaluated the feasibility and acceptability of…
Routine AI assistance may lead to loss of skills in health professionals who perform colonoscopies
An observational study of over 1,400 colonoscopies found that the rate at which experienced health…
Integrative scATAC-seq and mtDNA mutation analysis reveals disease-driven regulatory aberrations in AML
Disruptions in transcriptional regulation during haematopoiesis can lead to abnormal haematopoietic differentiation and the development…
Dynamin 1-mediated endocytic recycling of glycosylated N-cadherin sustains the plastic mesenchymal state to promote ovarian cancer metastasis
Ovarian cancer represents the most lethal gynaecological malignancy, with most patients presenting with peritoneal metastasis…
Zombie cancer cells give cold shoulder to chemotherapy
Cancer is the leading cause of disease-related death in childhood. This is in part due…
A progressive evolution in virtual MRI imaging for tumour detection
During magnetic resonance imaging (MRI) procedures, contrast agents, such as the rare metal gadolinium, can…
New treatment eliminates bladder cancer in 82% of patients
A new drug-releasing system, TAR-200, eliminated tumours in 82% of patients in a phase 2 clinical…